Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Michelet

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Travel Medicine and Infectious Disease|September 17, 2014
Prevalence of and risk factors for acute mountain sickness among a cohort of high-altitude travellers who received pre-travel counsellingMaud Santantonio, Jean-Marc Chapplain, Pierre Tattevin, et al.
AIDS (London, England)|April 13, 2004
Yellow fever vaccine is safe and effective in HIV-infected patientsPierre Tattevin, Agnès Geremy Depatureaux, Jean Marc Chapplain, et al.
The American Journal of Medicine|October 6, 2010
Should we systematically perform central nervous system imaging in patients with Whipple's endocarditis?Sophie Besnard, Anne Cady, Erwan Flecher, et al.
The Journal of Infectious Diseases|February 28, 2002
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimenVincent Le Moing, Rodolphe Thiébaut, Geneviève Chêne, et al.
Antiviral Therapy|April 11, 2015
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohortCamelia Protopopescu, François Raffi, Bruno Spire, et al.
Medical Care|February 25, 2012
Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationshipKarine Lamiraud, Jean-Paul Moatti, François Raffi, et al.
Antiviral Therapy|February 6, 2004
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up studyMaria Patrizia Carrieri, François Raffi, Charlotte Lewden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2015
Heart transplantation as salvage treatment of intractable infective endocarditisMarie Aymami, Matthieu Revest, Caroline Piau, et al.
HIV Clinical Trials|March 11, 2011
Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infectionJean-Marc Chapplain, Pierre Tattevin, Dominique Guyader, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2008
Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapyMarie Préau, Catherine Leport, Virginie Villes, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Travel Medicine and Infectious Disease|September 17, 2014
Prevalence of and risk factors for acute mountain sickness among a cohort of high-altitude travellers who received pre-travel counsellingMaud Santantonio, Jean-Marc Chapplain, Pierre Tattevin, et al.
AIDS (London, England)|April 13, 2004
Yellow fever vaccine is safe and effective in HIV-infected patientsPierre Tattevin, Agnès Geremy Depatureaux, Jean Marc Chapplain, et al.
The American Journal of Medicine|October 6, 2010
Should we systematically perform central nervous system imaging in patients with Whipple's endocarditis?Sophie Besnard, Anne Cady, Erwan Flecher, et al.
The Journal of Infectious Diseases|February 28, 2002
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimenVincent Le Moing, Rodolphe Thiébaut, Geneviève Chêne, et al.
Antiviral Therapy|April 11, 2015
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohortCamelia Protopopescu, François Raffi, Bruno Spire, et al.
Medical Care|February 25, 2012
Adherence to and effectiveness of highly active antiretroviral treatment for HIV infection: assessing the bidirectional relationshipKarine Lamiraud, Jean-Paul Moatti, François Raffi, et al.
Antiviral Therapy|February 6, 2004
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up studyMaria Patrizia Carrieri, François Raffi, Charlotte Lewden, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 30, 2015
Heart transplantation as salvage treatment of intractable infective endocarditisMarie Aymami, Matthieu Revest, Caroline Piau, et al.
HIV Clinical Trials|March 11, 2011
Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infectionJean-Marc Chapplain, Pierre Tattevin, Dominique Guyader, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 25, 2008
Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapyMarie Préau, Catherine Leport, Virginie Villes, et al.
Pageof 6